Evidence map›Paper›PMID 35441211›Full record

ArticlePediatrics2022

Parents' Experiences and Needs Regarding Infant Sickle Cell Trait Results.

Alexandra M Sims, Shamaree J Cromartie, Lelia Gessner, Andrew Campbell, Tumaini Coker, C Jason Wang, Beth A Tarini

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Alexandra M SimsDivision of General and Community Pediatrics, Children's National Hospital, Washington, District of Columbia.
Shamaree J CromartieVirginia Department of Health, Richmond, Virginia.
Lelia GessnerDivision of General and Community Pediatrics, Children's National Hospital, Washington, District of Columbia.
Andrew CampbellDepartment of Pediatrics, The George Washington University School of Medicine, Washington, District of Columbia.
Tumaini CokerSeattle Children's Hospital, Seattle, Washington.
C Jason WangDepartments of Pediatrics and Medicine, Stanford University School of Medicine, Stanford, California.
Beth A TariniDivision of General and Community Pediatrics, Children's National Hospital, Washington, District of Columbia.
Children's National · USGeorge Washington University · USSeattle Children's Hospital · USStanford University · USUniversity of Cincinnati Medical Center · USVirginia Department of Health · US

Funding

Unresolved Issues in Newborn Screening: Quantifying the Harms of a False Positive ResultR01HD095068 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI TARINI, BETH A · 2018 to 2022
$3.6M
Research in Academic Pediatrics Investigator Development (RAPID)R25DK096944 · NIDDK · ACADEMIC PEDIATRIC ASSOCIATION · PI GLENN FLORES · 2012 to 2026
$2.0M
NICHD NIH HHS R01 HD095068NIDDK NIH HHS R25 DK096944
6 · The paper itself

Abstract

BACKGROUND AND

objectiveSickle cell trait (SCT) has reproductive implications and can rarely cause health problems. SCT counseling improves parent knowledge but is infrequently received by children with SCT compared with children with cystic fibrosis carrier status. There are no national guidelines on SCT disclosure timing, frequency, or counseling content. Parents' experiences with SCT disclosure and counseling are poorly understood but could inform the development of guidelines. We explored parents' experiences with and desires for SCT disclosure and counseling for their infants with SCT identified via newborn screening.

methodsParents of infants 2 to 12 months old with SCT were recruited through a state newborn screening program for semistructured interviews to explore their experiences with and desires for SCT disclosure and counseling. Inductive thematic analysis was conducted.

resultsSixteen interviews were completed from January to August 2020. Most parents reported that SCT disclosure occurred soon after birth, in person, and by the child's physician. Five themes were identified: parent knowledge before child's SCT disclosure, family planning, the dynamics of SCT disclosure and counseling, emotions and actions after SCT disclosure, and parent desires for the SCT disclosure and counseling process. Two primary parent desires were revealed. Parents want more information about SCT, particularly rare symptomatology, and they want SCT counseling repeated once the child approaches adolescence.

conclusionParents report receiving their child's SCT diagnosis in the early newborn period from their child's doctor but indicate they receive incomplete information. Opportunities exist in primary care pediatrics to better align SCT disclosure timing and counseling content with parent desires.

Indexed as

Sickle Cell TraitAdolescentChildCounselingDisclosureHumansInfantInfant, NewbornNeonatal ScreeningParents

Identifiers

PMID35441211
PMCPMC9647577
OpenAlexW4224236897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.